Hyunghoon Cho is an Assistant Professor at Yale School of Medicine in the Department of Biomedical Informatics & Data Science, with a secondary appointment in the Department of Computer Science. He received his PhD in Electrical Engineering and Computer Science from MIT (2019) and MS/BS in Computer Science from Stanford University (2013). His research focuses on computational challenges in biomedical data privacy, single-cell genomics, and network biology. Assistant Professor (Primary): Biomedical Informatics & Data Science Assistant Professor (Secondary): Computer Science Appointments: Yale School of Medicine | Broad Institute (Schmidt Fellow) Research Themes: Privacy-Enhancing Technologies for genomic and health data Scalable AI/ML tools for omics data analysis Structured biological modeling for system-level discovery His work includes secure GWAS, transcriptomic privacy assessment, and sfkit - a federated genomic analysis toolkit. He received the NIH Director's Early Independence Award and leads NSF-funded projects on confidential genome analytics. Awards: NIH Director's Early Independence Award Lab Members: Haris Smajlović (Postdoc), Vincent Angelo (CBB MS), Denis Loginov (Senior Software Engineer), Lucy Zheng (CBB PhD)
Wim Gevers is a faculty member at the Université libre de Bruxelles (ULB) and leads the CS4S – Cognitive Control & Sleep laboratory within the CRCN research centre. His work bridges cognitive psychology, neuroscience and sleep research to understand how the brain exerts control over thoughts and actions and how sleep contributes to these processes. Research Interests Cognitive Control & Metacognition: Investigating how subjective experiences such as confidence and the "urge-to-err" guide strategic adjustments in behaviour. Working Memory & Ordinal Cognition: Examining how order information is maintained and manipulated, and how these processes relate to mathematical competence. Sleep, Memory & Decision Making: Exploring how sleep-dependent consolidation influences motor learning and decision strategies. Across his 2022–2025 publications a clear trend emerges: a focus on metacognitive monitoring —how humans evaluate their own cognitive states—and the role of emotional and temporal context in shaping those evaluations. Studies range from reaction-time introspection and confidence judgements in perceptual tasks to the impact of aging and depression on metacognitive accuracy. Doctoral Supervision & Mentoring Whitney Stee (PhD 2024) – Sleep-dependent structural brain reorganization & motor learning Gaia Corlazzoli (PhD 2024) – Subjective experience in decision-making Myrtille Dewulf (PhD 2023) – Ordinal coding mechanisms in working memory Rebeca Sifuentes-Ortega (PhD 2023) – REM sleep and memory reactivation All dissertations were defended at ULB, Faculté des Sciences psychologiques et de l’éducation, with Wim Gevers formally listed as Promotor . Laboratory & Collaborative Networks As head of CS4S, Gevers coordinates a multidisciplinary team that combines behavioural experimentation, EEG/MEG, computational modelling and sleep polysomnography. The lab is embedded in the larger CRCN ecosystem, fostering collaborations with groups such as CO3 (consciousness), LCLD (language & deafness), and UR2NF (neurofunctional imaging).
Dr. Birgit Frauscher is the Lincoln Financial Group Distinguished Professor in Neurobiology at Duke University School of Medicine, where she serves as Professor of Neurology and holds a secondary appointment in the Department of Biomedical Engineering at the Duke Pratt School of Engineering. She is currently the Director of the Duke Comprehensive Epilepsy Center and leads the Analytical Neurophysiology (ANPHY) Lab. Her clinical and research work focuses on epilepsy and sleep medicine, utilizing both invasive and non-invasive electrical recordings to study brain activity in humans. Dr. Frauscher completed her medical training, neurology residency, and subspecialty training in electroencephalography, epilepsy, and sleep medicine at the Medical University of Innsbruck in Austria. After completing her clinical training in 2008, she earned her habilitation degree in 2011. She further specialized in intracranial EEG and signal analysis during a visiting professorship at the Montreal Neurological Institute and Hospital, McGill University (2013-2015), where she later served as an Attending Epileptologist and Group Leader of Epilepsy. Her research interests focus on developing novel seizure-independent EEG markers for the epileptogenic zone, investigating sleep-epilepsy interactions, and using intracranial EEG to study brain physiology during wakefulness and sleep. Her work aims to improve epilepsy diagnosis, prognosis, and treatment outcomes by better localizing the epileptic focus. Dr. Frauscher's recent publications demonstrate her continued leadership in epilepsy research, with over 170 peer-reviewed papers and an H-index of 62. Dr. Frauscher has received several prestigious awards including the Clinician-Scientist awards of the FRSQ (2018-2023), the Michael Prize of the International League against Epilepsy (2019), and the Ernst Niedermeyer Prize from the Austrian Epilepsy Society (2015). Her scholarly work has significantly advanced clinical knowledge in epilepsy and sleep medicine, establishing her as a leading figure in the field. As Director of the Duke Comprehensive Epilepsy Center and head of the ANPHY lab, Dr. Frauscher oversees a research program dedicated to advancing neuroscience through innovative approaches to studying brain activity. Her lab employs quantifiable tools to investigate neurophysiological and pathological processes related to epilepsy and sleep, with the ultimate goal of improving patient outcomes through better understanding of brain function.
Andrea Tagliasacchi is an Associate Professor at Simon Fraser University's School of Computing Science, holding the Visual Computing Research Chair. He is also a part-time (20%) staff research scientist at Google DeepMind (Toronto) and an associate professor (status-only) at the University of Toronto's computer science department. His research focuses on 3D visual perception at the intersection of computer vision, graphics, and machine learning. Education: EPFL – Postdoc Simon Fraser University – PhD (NSERC Alexander Graham Bell Fellow) Politecnico di Milano – MSc (Gold Medalist) Research Interests: His work emphasizes 3D reconstruction, neural fields, and applications in robotics, autonomous systems, and augmented reality. Recent advancements include scalable 3D Gaussian splatting, robust neural rendering techniques, and diffusion models for 4D generation. Notable Articles: Recent work spans real-time differentiable ray tracing, stochastic rasterization for 3D Gaussian splats, and generative image composition using neural fields. His publications often blend theoretical contributions with practical applications in CVPR, SIGGRAPH, and NeurIPS. Awards: 2015 SGP Best Paper Award 2020 CVPR Best Student Paper Award 2024 CVPR Best Paper Honorable Mention Advising & Grants: Advised 14+ PhD/MSc students (e.g., Baptiste Angles, Sara Sabour) and co-advised with notable figures like Geoffrey Hinton. Active in grants involving neural field compression, robotic perception, and generative AI. Labs & Teams: Leads a lab at SFU focused on 3D vision and neural fields, collaborating with industry partners like Google Brain and Samsung Research.
David S. Eisenberg is a Professor of Chemistry and Biochemistry and Biological Chemistry at the University of California, Los Angeles, where he also serves as Director of the UCLA-DOE Institute for Genomics and Proteomics and as an HHMI Investigator. His research focuses on protein interactions, particularly the structural basis for conversion of normal proteins to the amyloid state and conversion of prions to the infectious state. Dr. Eisenberg earned his undergraduate degree in biochemical sciences from Harvard College and his D.Phil. degree in theoretical chemistry from Oxford University on a Rhodes Scholarship. His postdoctoral research was on ice and water with Walter Kauzmann at Princeton and in protein crystallography with Richard Dickerson. He joined the UCLA faculty after his postdoctoral studies. Dr. Eisenberg and his research group focus on protein interactions in amyloid and prion diseases. These diseases involve protein aggregation where normal functional proteins convert to abnormal aggregated forms. Systemic amyloid diseases like dialysis-related amyloidosis result from fiber accumulation until organ failure, while neurodegenerative diseases like Alzheimer's, Parkinson's, ALS, and prion conditions appear to be caused by smaller oligomers. In 2005, his team determined the atomic-level structure for the amyloid fiber spine, revealing a 'steric zipper' of two parallel beta sheets packed across a dry interface. Since then, they've determined approximately 90 amyloid spines from 15 disease-related proteins. In 2010, they identified the structure of a toxic amyloid-related oligomer consisting of six anti-parallel beta strands forming a cylindrical barrel. His recent publications demonstrate continued innovation in amyloid research, with focus areas including structural prediction of amyloid formation, mechanisms of tau fibril disassembly in Alzheimer's disease, cryo-EM analysis of amyloid polymorphism, and structure-based design of inhibitors for amyloid toxicity. His work integrates computational, structural, and biochemical approaches to understand protein aggregation across multiple disease contexts. Dr. Eisenberg has received numerous prestigious awards and honors: National Academy of Sciences Member American Philosophical Society Member Institute of Medicine Member Howard Hughes Medical Institute Investigator Biophysical Society Emily M. Gray Award Harvard Westheimer Medal UCLA Seaborg Medal Technion - Israel Institute of Technology Harvey Prize in Human Health As Director of the UCLA-DOE Institute for Genomics and Proteomics and an HHMI Investigator, Dr. Eisenberg leads significant research initiatives in protein structure and aggregation. His laboratory combines X-ray crystallography, bioinformatics, and biochemical techniques to investigate protein interactions, with particular emphasis on amyloid-forming proteins and their role in disease. The Eisenberg Lab, located in Boyer Hall at UCLA, maintains an active research program investigating the structural basis of protein aggregation. The lab continues to build on its landmark discoveries of amyloid structures while exploring new frontiers in understanding protein misfolding diseases and developing potential therapeutic interventions.
Raquel Fernández is Full Professor of Computational Linguistics and Dialogue Systems at the University of Amsterdam, where she leads the Dialogue Modelling Group at the Institute for Logic, Language & Computation (ILLC). As Vice-Director for Research at ILLC and a Fellow of the ELLIS Society, she bridges computational linguistics, cognitive science, and artificial intelligence through her research on language use in multimodal and conversational contexts. PhD in Computational Linguistics from King's College London Prior research positions at University of Potsdam and Stanford University's CSLI Her work explores how cognitive constraints, social interaction, and perception shape language use, with a focus on: Visually-grounded language processing Multimodal dialogue modeling Model uncertainty and calibration Language grounding in multimodal data Language learning and semantic change Dialogue reference resolution Recent publications analyze multimodal reasoning limitations, cross-lingual knowledge consistency, and uncertainty modeling in dialogue systems. She has received multiple accolades including an ERC Consolidator Grant , NWO VENI/VIDI/Aspasia fellowships , and EMNLP/GenBench awards . Outstanding Paper Award (EMNLP 2023) Best Data Award (GenBench Workshop 2023) ELLIS Society Fellow ERC Consolidator Grant #819455 recipient NWO VENI/VIDI/Aspasia awardee As a leader in academic service, she serves on the SIGDAT Executive Committee and chairs multiple conference committees. Her lab develops models for multimodal dialogue, visual storytelling, and grounded language understanding.
David Vocadlo is a Distinguished Professor of Chemistry and Molecular Biology & Biochemistry at Simon Fraser University (SFU), holding the Canada Research Chair in Chemical Biology. His research focuses on Chemical Glycobiology, investigating carbohydrate-processing enzymes and developing chemical tools to study glycan roles in health and disease. His lab explores O-GlcNAc signaling, neurodegenerative disorders (e.g., Alzheimer’s, Parkinson’s), and enzyme inhibitors for therapeutic applications. Education: PhD from University of British Columbia (UBC), followed by a CIHR postdoctoral fellowship at UC Berkeley. Key roles include E.W.R. Steacie Memorial Fellow and Royal Society Fellow. Research highlights include O-GlcNAcase inhibitors for neuroprotection, glycan structure-function relationships, and enzyme activity imaging tools. Collaborates globally with experts in glycobiology and employs cutting-edge techniques like chemical synthesis, mass spectrometry, and live-cell imaging. Awards: Distinguished Professor title, Canada Research Chair, Royal Society Fellowship. Active in training researchers through SFU’s graduate programs, emphasizing interdisciplinary approaches. Lab members work on topics ranging from enzyme mechanisms to disease modeling.
Ashli Owen-Smith is a behavioral scientist affiliated with the School of Public Health at Georgia State University , where her research focuses on mental health disparities, suicide prevention, and integrative/complementary approaches for complex mental-physical health conditions. She works with underserved populations including refugees/immigrants, incarcerated individuals, and LGBTQ+ communities through community-based participatory research and mixed-methods frameworks. Her current projects are funded by CDC , DBHDD , and DPH . Education: Ph.D. in Behavioral Sciences (Emory, 2009), S.M. in Public Health (Harvard, 2005), B.A. in Psychology (Smith College, 2001) Her research spans mental health , trauma , suicide prevention , and mindfulness-based interventions . Recent work examines telehealth adaptations for chronic pain and mental health, vaccine hesitancy in refugee communities, and social determinants of suicide . She leads studies on gender-affirming care and health disparities in LGBTQ+ populations. Key article trends include epidemiological analysis of suicide risk factors, COVID-19 impacts on mental health, ICD-10 coding for autism, and complementary medicine in trauma recovery. Subfields span telehealth , health equity , mental-physical comorbidity , and community engagement . Students she has mentored include C.A. Scarlett , T. Griner , and M.M. Sesay . Her work integrates public health policy , clinical research , and health systems analysis .
Aapo Hyvärinen is a Professor of Computer Science at the University of Helsinki , affiliated with the Helsinki Institute for Information Technology and the Helsinki Probabilistic Machine Learning Lab . He previously held the position of Professor of Machine Learning at the Gatsby Computational Neuroscience Unit, University College London (2016-2019). Education : Undergraduate Mathematics at University of Helsinki, Vienna, and Paris; Ph.D. in Information Science from Helsinki University of Technology (1997) His research focuses on machine learning and computational neuroscience , particularly: Independent Component Analysis (ICA) Natural Image Statistics Causal Representation Learning Neural Signal Processing Applications to brain imaging (MEG, CryoEM) Recent publications emphasize causal discovery , identifiable machine learning , and nonlinear ICA . Key projects include: VETURI (AI for health) DIGIMIND (AI in mental health) CIFAR grants (2022-2025) Scientific awards : Highly Cited Researcher (2010) He serves as Action Editor for the Journal of Machine Learning Research and Neural Computation , and has held Area Chair roles at NeurIPS, ICML, ICLR, AISTATS, and UAI conferences. His work bridges theoretical machine learning with neuroscience and philosophical implications of artificial intelligence .
Univ-Prof. Dr. med. Malek Bajbouj serves as Director of the Institute for Affective Neuroscience and Emotion Modulation at Charité – University Medicine Berlin's Campus Benjamin Franklin (CBF), operating within the Department of Neurology, Neurosurgery and Psychiatry (CC 15). His position integrates clinical leadership with translational neuroscience research focused on severe mental illnesses. Dr. Bajbouj's research program centers on affective neuroscience and emotion dysregulation mechanisms in psychiatric disorders, particularly schizophrenia spectrum conditions and depression. He pioneers multimodal intervention approaches combining neuromodulation (tDCS), oxytocin augmentation, mindfulness therapies, and digital health tools. His work emphasizes translational biomarker development using neuroimaging, machine learning, and physiological stress parameter analysis to personalize treatment for treatment-resistant populations. Analysis of his 2023-2025 publications reveals three dominant research trajectories: (1) novel treatment combinations for negative symptoms in schizophrenia (oxytocin + mindfulness, yoga therapy); (2) real-world implementation of neuromodulation (at-home tDCS protocols, technical efficacy monitoring); and (3) global mental health responses to crises (pandemic impacts on vulnerable groups, culturally adapted refugee interventions). His methodology consistently employs rigorous randomized controlled trials with embedded biomarker studies. As director of his eponymous institute, Dr. Bajbouj leads a multidisciplinary team conducting neuroimaging studies, clinical trials, and international collaborations focused on emotion modulation pathways. The institute coordinates research across CC 15's clinical infrastructure at CBF Building V, with particular emphasis on bridging laboratory neuroscience with clinical psychiatry through the DepressionDC and OXYMIND trial frameworks.
Prof. Waldemar Kolanus leads the Molecular Immunology and Cell Biology department at the University of Bonn's Life & Medical Sciences Institute (LIMES) . His research bridges immunoregulation , stem cell dynamics , and metabolic stress responses in immune cells. Unit 2 member at LIMES Principal investigator in SFB 704 and ImmunoSensation Cluster Leads a multidisciplinary lab with postdocs, PhD students, and technical staff His work focuses on intracellular signaling pathways connecting immune activation to tissue homeostasis, particularly through: Cytohesin proteins in integrin-mediated adhesion and migration TRIM71 in stem cell regulation and congenital hydrocephalus High-salt environments affecting macrophage function Publication trends show expertise in immune cell migration , genetic models , and chemical inhibition , with frequent use of mice and zebrafish for in vivo studies. Key articles explore: TRIM71's dual role in auditory development and germ cell maintenance Cytohesin family's Golgi regulation and insulin signaling Ruxolitinib's off-target migration inhibition of dendritic cells Contact details: Address: LIMES Institute, Carl-Troll-Straße 31, Bonn Email: kolanus.sekretariat@uni-bonn.de Phone: +49 228 73-62788
Shih-Fu Chang is the Dean of Columbia Engineering and holds the Morris A. and Alma Schapiro Professorship at Columbia University. His research focuses on computer vision, machine learning, and multimedia information retrieval. He is recognized as a foundational figure in the field of content-based visual search and has pioneered innovations in image/video search engines, crime prevention systems, and brain-machine interfaces. His leadership roles include Chair of Columbia's Electrical Engineering Department (2007-2010), Editor-in-Chief of the IEEE Signal Processing Magazine (2006-2008), and Senior Executive Vice Dean at Columbia Engineering, where he drives strategic planning and international collaboration. Dr. Chang has received prestigious awards including the ACM Multimedia Technical Achievement Award, IEEE Signal Processing Technical Achievement Award, and IEEE Kiyo Tomiyasu Award. He is a Fellow of AAAS, ACM, and IEEE, and an Academician of Academia Sinica. His recent work emphasizes multimodal reasoning, few-shot learning, and vision-language systems, with applications in healthcare diagnostics and multimedia benchmarking. His research spans cross-modal understanding, event extraction, and adaptive AI systems. Key contributions include systems like Ferret-v2 for multimodal grounding and RESIN for schema-guided event tracking. He has advised multiple startups and actively contributes to curriculum development in AI and engineering education.
Matthew B. Blaschko is a Professor in the Department of Electrical Engineering at KU Leuven, Belgium. He serves as director of the KU Leuven ELLIS unit and is a fellow in the ELLIS Health program. He is a Core PI in the Flanders AI Research Program, working as a workpackage lead for Decision Support Systems and Medical Imaging. Blaschko is also a member of the KU Leuven Institute for Artificial Intelligence and one of the leaders of the working group on Machine Learning and Data Science. Professor Blaschko received his B.S. from Columbia University, M.S. from the University of Massachusetts Amherst, and Dr. rer. nat. from Technische Universität Berlin (awarded for work at Max Planck Institutes Tübingen). He was a Newton International Fellow at the University of Oxford and received his Habilitation (HDR) from École Normale Supérieure de Cachan. Prior to joining KU Leuven, he was a Permanent Research Scientist in the INRIA Saclay Research Center and a Faculty Member at Ecole Centrale Paris. His research focuses on machine learning techniques applied to visual data, with particular emphasis on calibration in deep learning, medical image analysis, and federated learning. Blaschko's work bridges theoretical foundations with practical applications, as evidenced by technology developed in his research being incorporated into MONA, software for ophthalmic image analysis. His research group has made significant contributions to the fields of model calibration, uncertainty estimation, and medical imaging analysis, with recent publications showing strong trends toward improving reliability of AI systems in medical contexts and advancing theoretical understanding of calibration metrics. Professor Blaschko has been recognized with several awards including the Université Paris-Saclay STIC Doctoral School Best Scientific Contribution Award, Best Paper Award at CVPR 2008, Main Award at DAGM 2008, and Best Student Paper Award at ECCV 2008. Professor Blaschko has supervised numerous PhD and Master's students, with current and former students including Deniz Soysal, Claire Marchal, Dongli Xu, Sebastian Gruber, Jiameng Li, Marco Mezzina, and many others working on diverse topics from Alzheimer's disease analysis to surgical phase recognition. His research has been supported by various funding sources including the Flanders AI Research Program. He has co-organized several influential workshops including the "Another Brick in the AI Wall: Building Practical Solutions from Theoretical Foundations" at CVPR 2025, Commands 4 Autonomous Vehicles workshop at ECCV 2020, and the Learning from Limited Labeled Data workshop series at NIPS 2017 and ICLR 2019. His laboratory focuses on machine learning for medical image analysis, with applications in ophthalmology, neurology, and surgical robotics. The group maintains active collaborations with medical institutions and participates in international challenges such as the KNee OsteoArthritis Prediction (KNOAP2020) challenge.
Dr. Sabine Krabbe is a Group Leader at the German Center for Neurodegenerative Diseases (DZNE) in Bonn, Germany, where she leads research on neural circuit mechanisms underlying adaptive learning and state-dependent decision-making. Her work integrates neuroscience, molecular biology, and behavioral approaches to understand how internal states influence behavior and how these processes are disrupted in neurological disorders. Dr. Krabbe's research focuses on the interactions between midbrain circuits of the substantia nigra and ventral tegmental area with their output structures such as the striatum and amygdala. She investigates how these networks integrate internal states with environmental cues to produce appropriate behavioral responses. Her laboratory employs state-of-the-art techniques including deep-brain calcium imaging at single-cell resolution in mice, opto- and pharmacogenetic manipulations, anatomical tracings, and molecular approaches to characterize neural circuit elements in detail. Her recent publications reveal significant insights into amygdala interneuron plasticity during fear learning, brain-wide representational drift in memory consolidation, and the molecular mechanisms underlying Parkinson's disease progression. Her work demonstrates how activity patterns within specific neural circuits change in early stages of neurodegenerative diseases and how this dysfunction contributes to cognitive deficits and emotional disturbances. Dr. Krabbe is actively involved in the neuroscience community, organizing the BonnBrain Conference 2026 and sharing research through social media platforms. She has established herself as an emerging leader in the field of systems neuroscience with a particular focus on the neural basis of emotional states and decision-making processes.
Dr. Nhiem Tran is a Senior Lecturer in the Department of Applied Chemistry and Environmental Science at RMIT University's School of Science, part of the STEM College. He joined RMIT in 2015 as a Vice Chancellor's Research Fellow after completing his PhD in Physics at Brown University (USA, 2012) and postdoctoral research at Rhode Island Hospital (USA), CSIRO, and the Australian Synchrotron. His research focuses on developing biomaterials for drug delivery, gene therapy, and medical implants, particularly lipid nanoparticles and 3D-printed metallic implants. He leads the Biomaterial Interfaces group, investigating self-assembled lipid nanoparticles for cancer and autoimmune disease treatments. His work has resulted in over 65 high-impact publications and numerous awards, including the RMIT Vice Chancellor's Research Fellowship and the Stein/Bellet Foundation Fellowship. Tran's funding comes from grants such as the ARC Discovery Project, mRNA Victoria, and the CASS Foundation. His research interests span nanomedicine, biomedical engineering, and materials science, with a focus on applications in drug delivery, bacterial infection control, and orthopaedic implants. Education: PhD in Physics (Brown University, 2012) Key Projects: 3D-printed diamond-titanium implants, lipid nanoparticle drug carriers, and antimicrobial coatings. He actively supervises postgraduate research in areas like nanomaterials for drug delivery and biomedical applications.
